{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:41:01Z","timestamp":1774467661881,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ijpharm.2016.01.068","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T11:49:33Z","timestamp":1454068173000},"page":"112-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration"],"prefix":"10.1016","volume":"501","author":[{"given":"Jingjing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zimei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.01.068_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0076-6879(08)03007-3","article-title":"Molecular imaging of tumor vasculature","volume":"445","author":"Cai","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2013.03.056","article-title":"Comparative anti-inflammatory activity of poly(amidoamine) (PAMAM) dendrimer\u2013dexamethasone conjugates with dexamethasone-liposomes","volume":"449","author":"Choksi","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0020","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1021\/bc900041f","article-title":"Synthesis of a labeled RGD-lipid its incorporation into liposomal nanoparticles, and their trafficking incultured endothelial cells","volume":"20","author":"Cressman","year":"2009","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2009.08.011","article-title":"Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel","volume":"140","author":"Danhier","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0030","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","article-title":"Dendrimer biocompatibility and toxicity","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1126\/science.2432664","article-title":"Angiogenic factors","volume":"235","author":"Folkman","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0040","first-page":"359","article-title":"Synthesis and performance study of folate-conjugated curcumin prodrug dendrimer derivative","volume":"40","author":"Gao","year":"2013","journal-title":"J. Int. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2007.04.037","article-title":"Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes","volume":"342","author":"Hatakeyama","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.gt.3302843","article-title":"Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid","volume":"14","author":"Hatakeyama","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2009.06.008","article-title":"A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo","volume":"139","author":"Hatakeyama","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","article-title":"Role of integrins in cell invasion and migration","volume":"2","author":"Hood","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0065","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.febslet.2007.06.067","article-title":"An apoptosis-related gene network induced by novel compound-cRGD in human breast cancer cells","volume":"581","author":"Huang","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0378-5173(02)00623-3","article-title":"The influence of surface modification on the cytotoxicity of PAMAM dendrimers","volume":"252","author":"Jevprasesphant","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4161\/mabs.3.5.16089","article-title":"Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer","volume":"3","author":"Julien","year":"2011","journal-title":"MAbs"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2007.12.003","article-title":"Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking","volume":"354","author":"Khalil","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/bc025633c","article-title":"Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores","volume":"14","author":"Kobayashi","year":"2003","journal-title":"Bioconjuge Chem."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0090","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2147\/IJN.S41555","article-title":"A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for smart small interfering RNA delivery and in vitro antitumor effects by human ether-\u00e0-go-go-related gene silencing in anaplastic thyroid carcinoma cells","volume":"8","author":"Li","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0095","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.biomaterials.2007.11.014","article-title":"Biologically active core\/shell nanoparticles self-assembled from cholesterol-terminated PEG\u2013TAT for drug delivery across the blood\u2013brain barrier","volume":"29","author":"Liu","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0100","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1021\/ma0106346","article-title":"Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible: high-efficiency DNA delivery","volume":"35","author":"Luo","year":"2002","journal-title":"Macromolecules"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0105","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2147\/IJN.S77152","article-title":"Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab","volume":"10","author":"Ma","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2014.04.008","article-title":"Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG","volume":"468","author":"Mei","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0115","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1073\/pnas.0803728105","article-title":"Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis","volume":"105","author":"Murphy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0120","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.addr.2005.09.014","article-title":"Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex","volume":"57","author":"Patri","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2007.08.033","article-title":"Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers","volume":"350","author":"Pisal","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2011.09.008","article-title":"Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals","volume":"420","author":"Qin","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"RiSau","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/mp050032z","article-title":"Enhanced antiproliferative activity of transferring-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention","volume":"2","author":"Sahoo","year":"2005","journal-title":"Mol. Pharm."},{"issue":"80","key":"10.1016\/j.ijpharm.2016.01.068_bib0145","article-title":"Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells","volume":"6","author":"Sarin","year":"2008","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0150","first-page":"161","article-title":"Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis","volume":"13","author":"Strijkers","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0155","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.addr.2005.09.018","article-title":"Dendrimers in biomedical applications-reflections on the field","volume":"57","author":"Svenson","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.drup.2005.10.002","article-title":"RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature","volume":"8","author":"Temming","year":"2005","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0165","first-page":"113","article-title":"Inhibition of proliferative and invasive capacities of breast cancer cells by arginine-glycine-aspartic acid peptide in vitro","volume":"15","author":"Yang","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejpb.2011.03.025","article-title":"RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for gloma","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.01.068_bib0175","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.biomaterials.2009.10.044","article-title":"Partly pegylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style","volume":"31","author":"Zhu","year":"2010","journal-title":"Biomaterials"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316300680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316300680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T17:57:35Z","timestamp":1537034255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316300680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0378517316300680"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.068","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}